Empery Asset Management, LP

Position in BNTC — Benitec Biopharma Inc.

CIK 1469336 NEW YORK, NY

Position in BNTC

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$324,186

-$422,590 QoQ

Shares Held

30,440

-45.1% QoQ

Ownership

0.089%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Empery Asset Management, LP holds $53,120,730 across 6 Biotechnology names. BNTC ranks #6 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	XFOR	X4 Pharmaceuticals, Inc	8,944,118	$36,939,207
2	DTIL	Precision Biosciences Inc	1,968,879	$10,828,834
3	TNYA	Tenaya Therapeutics, Inc.	4,286,933	$2,966,557
4	MSLE	Satellos Bioscience Inc.	230,100	$1,295,463
5	PMN	ProMIS Neurosciences Inc.	60,353	$766,483
6	BNTC	Benitec Biopharma Inc. This page	30,440	$324,186

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$324,186	30,440	-45.1%	Shares	Sole	2026-05-08
2025-12-31	$746,776	55,440	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.